Skip to content

Information Note: New Fair Share Funding Targets for TB Research 0.1% -> 0.15%

Publication • 2023
In 2017 Treatment Action Group and partners introduced the “fair share” funding targets for TB research.

TAG Mourns the Loss of Dr. Stephaun Elite Wallace

Statement / Press • 2023
TAG extends our deepest condolences to the family, friends and loved ones of Dr. Stephaun Elite Wallace, PhD, MS. Dr. Wallace was a treasure to all who knew and worked with him, and his legacy of mentorship and community engagement in the HIV research landscape will be felt for generations.

TAG Encouraged by J&J Deal to Reduce Bedaquiline Prices, but Company’s Action Falls Short of Community Demands

Statement / Press • 2023
After over a year of sustained advocacy from the TB community demanding that Johnson & Johnson publicly commit to non-enforcement or withdrawal of secondary patents on bedaquiline filed in 66 low- and middle-income countries (LMICs)...

SMART4TB CONSORTIUM ANNOUNCES COMMUNITY PARTNERS

Statement / Press • 2023
Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) is a five-year cooperative agreement made possible by the United States Agency for International Development (USAID), with the assistance of the American people, that aims to transform tuberculosis (TB) prevention and care.

TB Vaccine Development: The Next Chapter Starts Now

Webinars • 2023
On Thursday, April 13, Treatment Action Group (TAG) presented this webinar about important developments in TB vaccine research.

Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline

Statement / Press • 2022
A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global Fund’s Expert Review Panel (ERP), an independent group of experts that reviews finished pharmaceutical products and makes recommendations on their use to the Global Fund.

Mourning Paul Farmer, Honoring His Legacy

Statement / Press • 2022
TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.

2022 TAG Update

Publication • 2022
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

Public Comment Submitted to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)

Letters • 2022
Comment submitted prior to their meeting on November 17, 2022. Comment is in regard to discussion and voting on recommendation related to implementation of the HIV Organ Policy Equity (HOPE) Act of 2013, specifically pertaining to HIV-positive to HIV-positive organ transplantation and pertaining to the following draft recommendation under consideration regarding removal of the statutory “NIH Research Criteria and IRB” requirement.

Community Representation in HIV Research: From Study Volunteers to Investigators

TAGline • 2022
By Cheriko A. Boone, Abraham Johnson, and Richard Jefferys In a 1989 article by Dr. Anthony Fauci, “AIDS — Challenges to Basic and Clinical Biomedical Research” — which preceded Treatment Action Group’s founding by just a few years — he described NIH/NIAID’s work on establishing the Community Programs for Clinical Research on AIDS, and he…
Back To Top